홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
The future of PCOS management: Disease modification through regenerative, metabolic, and digital therapeutics | Synapse
March 3, 2026
The future of PCOS management: Disease modification through regenerative, metabolic, and digital therapeutics
RA
Ruhi Arisha
SS
Shivam Sengupta
HD
Hitesh Kumar Dewangan
Chandigarh University
See all
Key Points
Disease modification through metabolic intervention improves insulin resistance in PCOS.
Patients using digital therapeutics show better engagement and lifestyle changes over time.
Regenerative therapeutics may balance hormonal levels more effectively than traditional methods.
These findings suggest a paradigm shift in how PCOS is managed and treated.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Arisha et al. (Thu,) studied this question.
synapsesocial.com/papers/69a76808badf0bb9e87e3560
https://doi.org/https://doi.org/10.1016/j.prp.2026.156397